MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
234.34
+2.61
+1.13%
After Hours: 234.35 +0.01 +0.00% 19:59 05/22 EDT
OPEN
233.00
PREV CLOSE
231.73
HIGH
235.50
LOW
232.72
VOLUME
5.46M
TURNOVER
--
52 WEEK HIGH
251.71
52 WEEK LOW
146.24
MARKET CAP
564.11B
P/E (TTM)
27.11
1D
5D
1M
3M
1Y
5Y
1D
The Week That Was, The Week Ahead: Macro and Markets, May 24
TipRanks · 18h ago
Salesforce, Dell Headline Earnings Week Amid Light Economic Calendar
Seeking Alpha · 1d ago
Did New Talc Verdict and MedTech Launch Just Shift Johnson & Johnson's (JNJ) Investment Narrative?
Simply Wall St · 1d ago
HDV: This May Not Be The ETF You Want, But It Could Be The One You Need Right Now
Seeking Alpha · 1d ago
3 Vanguard Dividend Funds for Low-Cost Income
Barchart · 1d ago
Johnson & Johnson: A Dividend King, But Priced Appropriately, Big Conference Slate
Seeking Alpha · 2d ago
Healthcare Stocks Are on Fire -- Don't Miss These Opportunities
The Motley Fool · 2d ago
Notable Friday Option Activity: JNJ, QUBT, QRVO
NASDAQ · 2d ago
More
About JNJ
Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.